Skip to content

In the BioHarmony Drug Report Database

Rufinamide

Banzel, Inovelon (rufinamide) is a small molecule pharmaceutical. Rufinamide was first approved as Banzel on 2007-01-16. It is used to treat seizures in the USA. It has been approved in Europe to treat epilepsy. Banzel's patent is valid until 2022-11-14 (FDA).
Trade Name Inovelon
Common Name Rufinamide
Indication epilepsy, seizures
Drug Class
Rufinamide
Get full access now